Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Directorate Change

14 Jul 2021 14:08

The Biotech Growth Trust Plc - Directorate Change

The Biotech Growth Trust Plc - Directorate Change

PR Newswire

London, July 14

14 July 2021

THE BIOTECH GROWTH TRUST PLC (the “Company”)

Directorate Change

The Board announces that Professor Dame Kay Davies CBE retired from the Board at the conclusion of the Company’s Annual General Meeting held today. It is further announced that following her retirement, Steve Bates has succeeded her as the Senior Independent Director.

- ENDS-

For further information please contact:

Mark PopeFrostrow Capital LLP020 3 008 4913

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.